Results from the BJFM menopause survey

When we launched our menopause survey, the single biggest aim was to understand the level of education and training among GPs regarding the menopause, and to determine the knowledge regarding the symptoms of the menopause and also the treatment options that would be considered in practice.

Additionally, as a journal, we wanted to use it as an opportunity to shape future editorial direction, using the results to fill in any knowledge gaps that might have been uncovered by the results. More than 200 people took the survey – 203 to be precise – exceeding our expectations, and this has given us a real handle on what health professionals are experiencing on the frontline, and the potential challenges that are faced.

To everyone who completed the survey, we’d like to thank you for your involvement and support.

The following article provides an overview and analysis of the survey.

Results from the BJFM Menopause Survey

Louise Newson Consultant Editor, Woman’s Health

Rob Mair Editor, British Journal of Family Health

This survey has been financed by Besins Healthcare (UK) Ltd who provided input in the content of the questions. BHUK/2017/560b – August 2017

References

1. NICE. Costing report: menopause: diagnosis and management—implementing the NICE guideline on menopause (NG23). NICE, 2015
2. NICE. Menopause: diagnosis and Management. Nice Guideline https://www.nice.org.uk/guidance/ng23/resources/menopause-diagnosis-and-management-pdf-1837330217413 [Accessed December 2017]
3. https://www.nhs.uk/conditions/menopause/ [Accessed December 2017]
4. Maclaran K, Panay N; Current concepts in premature ovarian insufficiency. Women’s Health (Lond) 2015; 11(2): 169–182
5. http://www.imsociety.org/manage/images/pdf/4429e3dd302aac259ad68c3be7f60599.pdf [Accessed December 2017]
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;288: 321-337
7. Marsden J. Long-term benefits and risks of HRT (Section 11): Breast Cancer. Post Reprod Health. 2016 Jun. 22(2): 85-91.
8. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in
   postmenopausal women: systematic review and meta-analysis. BMJ 2008;336:1227-31
9. NHS Choices https://www.nhs.uk/conditions/hormonereplacement-therapy-hrt/ [Accessed December 2017]
10. British Menopause Society. HRT Guide https://thebms.org.uk/_wprs/wp-content/uploads/2016/04/HRT-Guide-160516.
    pdf [Accessed December 2017]